Rapid Micro Biosystems Announces Preliminary Unaudited

Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth...

Related Keywords

Netherlands ,Germany ,Massachusetts ,United States ,Switzerland ,Samsung Biologics ,Company Growth ,Securities Exchange ,Company Annual Report On Form ,Rapid Micro Biosystems Inc ,Twitter ,Exchange Commission ,Nasdaq ,Healthcare Conference ,Micro Biosystems ,Fourth Quarter ,Preliminary Unaudited Revenue ,Growth Direct ,Unaudited Full Year ,Rapid Micro Biosystems ,Growth Direct System ,Securities Act ,Securities Exchange Act ,Annual Report ,Investor Relations ,Nasdaq Rpid ,Nc ,Utomation ,Icrobiology ,Ualitycontrol ,Ipid ,Apidmicrobio ,Healthcare ,